Anticonvulsant Market for Fibromyalgia - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

  • Single User License $3500

Anticonvulsant Market for Fibromyalgia - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

Status : January, 2022 | Pharmaceutical

Report Digest


Anticonvulsant Market for Fibromyalgia: Snapshot

Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons when a person gets seizures. Anticonvulsants also keep the seizure within the brain from spreading to other areas. Anticonvulsants are used extensively for the treatment of fibromyalgia and are thus, expected to be in continued demand during the period from 2017 to 2025. The growing incidences of epilepsy and need for managing pain due to migraines, and rising cases of fibromyalgia worldwide will boost the global anticonvulsant market for fibromyalgia in the coming years.

The report takes into account all the leading factors boosting the growth of the anticonvulsant market. It also studies the definition, causes, prevention methods, and treatment options that are available for fibromyalgia. Fibromyalgia causes pain all over the body. The patient also experiences tender points in different parts of the body such as neck, back, hips, arms, shoulders, and legs, when pressure is applied. Thus, the need for effective treatment options for the treatment of this painful disorder will boost the growth of the global anticonvulsant market for fibromyalgia in the coming years.

Global Anticonvulsant Market for Fibromyalgia: Overview 

The global anticonvulsant market used for fibromyalgia demonstrates a massive potential for future growth. The efficiency of anticonvulsants in the treatment of various neurological disorders, specifically fibromyalgia, is likely to increase their popularity, reflecting greatly on their demand over the forthcoming years. 

The increasing prevalence of fibromyalgia, boosted substantially by the ever-rising base of geriatric population and the increasing expenditure on healthcare, thanks to the augmented disposable income of people have been acting as the key factors driving this market and are expected to maintain its growth pace in the near future too. 

Global Anticonvulsant Market for Fibromyalgia: Drivers and Restrains 

Currently, a number of both, patented and off-label anticonvulsant drugs, are being used in the treatment of fibromyalgia. Although with expired patents, Topiramate, levetiracetam, divalproex sodium, lamotrigine, oxcarbazepine, and carbamazepine are driving the global market for anticonvulsants used for the treatment of fibromyalgia considerably. In addition, a robust pipeline of anticonvulsants drugs is waiting for U.S. FDA approval, which, post approval, is expected to add significantly to this market in the years to come. The rising preference for generic products is also projected to influence anticonvulsant market remarkably over the next few years. 

On the other hand, the stringent regulatory guidelines for the approval of drugs may create obstacles in the growth trajectory of this market to some extent. However, the advancement in medical and healthcare infrastructure in emerging economies is likely to normalize their effects on this market in the near future. 

Global Anticonvulsant Market for Fibromyalgia: Geographical Analysis 

The global market for anticonvulsant used for fibromyalgia registers its presence across Asia Pacific, Europe, North America, and the Rest of the World. Due to the presence of a large pool of established players, North America has acquired the leading position in this market. The high disposable income of consumers that enables them to afford expensive treatments, is likely to maintain the growth pace of the North America market for anticonvulsants for fibromyalgia over the next few years. Apart from this, the growing awareness among consumers regarding health and wellness and the rising number of neurological disorders are also expected to further drive this market. 

Asia Pacific, on the other hand, is anticipated to offer the most promising opportunities for the growth of the worldwide anticonvulsant market used for fibromyalgia in the near future. The improvement in economic conditions, rise in purchasing power, and the increase in the living standard of people in Asian countries, such as India and China, are likely to boost this regional market over the years to come. The substantial progress in the medical tourism industry in this region is also projected to reflect positively on the demand for anticonvulsants in Asia Pacific in the near future. 

Global Anticonvulsant Market for Fibromyalgia: Companies Mentioned in the Report 

Pfizer Inc., GlaxoSmithKline Inc., UCB Group, Novartis AG, Johnson & Johnson (J&J), and Abbott Laboratories are some of the leading players operating in the global market for anticonvulsants used for fibromyalgia.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?